Subscribe Now Subscribe Today
Research Article

Control of Coliform Mastitis with J5 Vaccine: Special Reference to J5 Vaccination in the Saudi Arabian Dairy Herds

A. M. Alluwaimi
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Coliform mastitis is widely incriminated as an environmental disease in modern dairy herds. J5 vaccine, Rc mutant with exposed common core antigen, was introduced to control the coliform mastitis. Experimental infection and field trial studies indicated the failure of the vaccine in preventing the infection. Nevertheless, it had significantly reduced the incidents of infection and/or the severity of the disease. In contrast, in Saudi Arabian dairy herds, J5 vaccine failed to accomplish, what was reported elsewhere. Further studies are advised to scrutinize the feasibility of the vaccine in control of the disease in Saudi Arabian dairy herds.

Related Articles in ASCI
Similar Articles in this Journal
Search in Google Scholar
View Citation
Report Citation

  How to cite this article:

A. M. Alluwaimi , 2001. Control of Coliform Mastitis with J5 Vaccine: Special Reference to J5 Vaccination in the Saudi Arabian Dairy Herds. Pakistan Journal of Biological Sciences, 4: 1576-1579.

DOI: 10.3923/pjbs.2001.1576.1579


1:  Baumgartner, J. and P. Glauser, 1985. Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid. Lancet, 2: 59-66.
Direct Link  |  

2:  Cullor, J.S., 1991. The role of vaccines in the prevention and moderation of clinical mastitis. Proceedings of the 30th Annual Meeting of the National Mastitis Council, (AMNMC'91), Arlington, Virginia, pp: 68-75.

3:  Dodd, F.H., 1983. Mastitis-progress on control. J. Dairy Sci., 66: 1773-1780.
Direct Link  |  

4:  Edacheril, M., 2000. Assessment of herd immunity to foot and mouth disease. Ph.D. Thesis, University of Reading, UK.

5:  Eberhart, R.J., 1984. Coliform mastitis. Vet. Clin. North Am., 6: 287-300.
PubMed  |  

6:  Eberhart, R.J., R.P. Natzke, F.S. Newbould, B. Nonnecke and P.S. Thompson, 1979. Coliform mastitis: A review. J. Dairy Sci., 61: 1-22.
CrossRef  |  Direct Link  |  

7:  Gill, R., W. Howard, K. Leslie and K. Lissemore, 1990. Economics of mastitis control. J. Dairy Sci., 73: 3340-3348.
CrossRef  |  PubMed  |  Direct Link  |  

8:  Green, M. and A.J. Bradely, 1998. Coliform mastitis: An evolving problem. Cattle Pract., 6: 91-91.

9:  Gonzales, R.N., J.S. Cullor and D.E. Jasper, 1989. Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine. Can. J. Vet. Res., 53: 301-305.
Direct Link  |  

10:  Hill, A.W., D.J. Heneghan and M.R. Williams, 1983. The opsonic activity of bovine milk whey for the phagocytosis and killing by neutrophils of encapsulated and non-encapsulated Escherichia coli. Vet. Microbiol., 8: 293-300.
PubMed  |  

11:  Hogan, J.S., W.P. Weiss, K.L. Smith, D.A. Todhunter and P.S. Schoenberger, 1995. Effects of an Escherichia coli J5 vaccine on mild clinical mastitis. J. Dairy Sci., 78: 285-290.
Direct Link  |  

12:  Hogan, J.S., W.P. Weiss, K.L. Smith, D.A. Todhunter and P.S. Schoenberger, 1992. Efficacy of an Escherichia coli J5 mastitis vaccine in an experimental challenge trial. J. Dairy Sci., 75: 415-422.
Direct Link  |  

13:  Hogan, J.S., K.L. Smith, D.A. Todhunter and P.S. Schoenberger, 1992. Field trial to determine efficacy of an Escherichia coli J5 mastitis vaccine. J. Dairy Sci., 75: 78-84.
Direct Link  |  

14:  Hogan, J.S., G.M. Tomita, D.A. Todhunter, K.L. Smith and P.S. Schoenberger, 1992. Opsonic activity of bovine serum and mammary secretion after Escherichia coli J5 vaccination. J. Dairy Sci., 75: 72-77.
Direct Link  |  

15:  Jones, T.O., 1990. Escherichia coli mastitis in dairy cattle: A review of the literature. Vet. Bull., 60: 205-220.

16:  Lachman, E., S.B. Pitsoe and S.L. Gaffin, 1984. Anti-lipopolysaccharide immunotherapy in management of septic shock of obstetric and gynecological origin. Lancet, 1: 981-983.

17:  Law, B.J. and I.M. Melvin, 1985. Age-related prevalence of human serum IgG and IgM antibody to the core glycolipid of Escherichia coli strain J5, as measured by ELISA. J. Infect. Dis., 151: 988-994.
PubMed  |  

18:  Morris, D.D., R.H. Whitlock and L.B. Corbeil, 1986. Endotoxemia in horses: Protection provided by antiserum to core lipopolysaccharide. Am. J. Vet. Res., 47: 544-550.

19:  National Mastitis Council, 1996. Current Concepts of Bovine Mastitis. 4th Edn., National Mastitis Council, Madison, WI., USA.

20:  Smith, K.L., H.R. Conrad, B.A. Amiet and D.A. Todhunter, 1985. Incidence of environmental mastitis as influenced by vitamin E and selenium. Kiel Mil Chwirtsch Forschungsber, 37: 482-482.

21:  Tomita, G.M., C.H. Ray, S.C. Nickerson, W.E. Owens and G.F. Gallo, 2000. A comparison of two commercially available Escherichia coli J5 vaccines against E. coli Intra mammary challenge. J. Dairy Sci., 83: 2276-2281.

22:  Tomita, G.M., C.H. Ray, S.C. Nickerson, W.E. Owens and B. Wren, 1998. Influence of route of vaccine administration against experimental Intra mammary infection caused by Escherichia coli. J. Dairy Sci., 81: 2159-2164.

23:  Tyler, J., H. Spears, J.S. Cullor, W. Smith, R. Nelson and J. Martin, 1991. Antigenic homology among gram-negative organisms isolated from cattle with clinical mastitis. J. Dairy Sci., 74: 1235-1242.

24:  Tyler, J., J.S. Cullor, S.J. Spier and B.P. Smith, 1990. Immunity targeting common core antigens of gram-negative bacteria. J. Vet. Intern. Med., 41: 17-25.

25:  Yancey, R.J., 1999. Vaccines and diagnostic methods for bovine mastitis: Fact and fiction. Adv. Vet. Med., 41: 257-272.

26:  Ziegler, E.J., J.A. McCutchan, J. Fierer, J.C. GlauserSadoff, H. Douglas and A.J. Braude, 1982. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N. Engl. J. Med., 307: 1225-1230.

©  2021 Science Alert. All Rights Reserved